Rapid initiation of cell cycle reentry processes protects neurons from amyloid-β toxicity
暂无分享,去创建一个
C. Heu | T. Fath | N. Haass | Yuanyuan Deng | L. Ittner | Y. Ke | Julia van der Hoven | Annika van Hummel | Astrid Feiten | S. W. Chua | S. Ippati | Gabriella Chan | Esmeralda Paric
[1] Erinna F. Lee,et al. BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival , 2019, Cell Death & Disease.
[2] M. Maffia,et al. Carnosine modulates the Sp1-Slc31a1/Ctr1 copper-sensing system and influences copper homeostasis in murine CNS-derived cells. , 2019, American journal of physiology. Cell physiology.
[3] Gavin D. Grant,et al. Accurate delineation of cell cycle phase transitions in living cells with PIP-FUCCI , 2018, Cell cycle.
[4] G. Perea,et al. Cell cycle reentry triggers hyperploidization and synaptic dysfunction followed by delayed cell death in differentiated cortical neurons , 2018, Scientific Reports.
[5] T. Verri,et al. Responsiveness of Carnosine Homeostasis Genes in the Pancreas and Brain of Streptozotocin-Treated Mice Exposed to Dietary Carnosine , 2018, International journal of molecular sciences.
[6] Nobuhiro Nakamura,et al. Ubiquitin System , 2018, International journal of molecular sciences.
[7] G. Halliday,et al. Selective Spatiotemporal Vulnerability of Central Nervous System Neurons to Pathologic TAR DNA-Binding Protein 43 in Aged Transgenic Mice. , 2018, The American journal of pathology.
[8] G. Halliday,et al. Region- and Cell-specific Aneuploidy in Brain Aging and Neurodegeneration , 2018, Neuroscience.
[9] Atsushi Miyawaki,et al. Genetically Encoded Tools for Optical Dissection of the Mammalian Cell Cycle. , 2017, Molecular cell.
[10] T. Fath,et al. Tau exacerbates excitotoxic brain damage in an animal model of stroke , 2017, Nature Communications.
[11] Reinhard Dummer,et al. Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure , 2017, EMBO molecular medicine.
[12] W. Tremel,et al. Dendritic Mesoporous Silica Nanoparticles for pH‐Stimuli‐Responsive Drug Delivery of TNF‐Alpha , 2017, Advanced healthcare materials.
[13] A. Ittner. SITE-SPECIFIC PHOSPHORYLATION OF TAU INHIBITS AMYLOID-β TOXICITY IN ALZHEIMER’S MICE , 2016, Alzheimer's & Dementia.
[14] Michael Z. Lin,et al. Fluorescent indicators for simultaneous reporting of all four cell cycle phases , 2016, Nature Methods.
[15] A. Karabay,et al. Expression of cell cycle proteins in cortical neurons-Correlation with glutamate-induced neurotoxicity. , 2016, BioFactors.
[16] Wolfgang Weninger,et al. Cell Cycle Phase-Specific Drug Resistance as an Escape Mechanism of Melanoma Cells. , 2016, The Journal of investigative dermatology.
[17] S. Dalton,et al. Utilizing FUCCI reporters to understand pluripotent stem cell biology. , 2016, Methods.
[18] K. Heese,et al. The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease , 2016, Molecular Neurobiology.
[19] Farzana Ahmed,et al. Imaging- and Flow Cytometry-based Analysis of Cell Position and the Cell Cycle in 3D Melanoma Spheroids. , 2015, Journal of visualized experiments : JoVE.
[20] G. Halliday,et al. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS , 2015, Acta Neuropathologica.
[21] B. Edgar,et al. FUCCI sensors: powerful new tools for analysis of cell proliferation , 2015, Wiley interdisciplinary reviews. Developmental biology.
[22] J. Power,et al. Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior , 2015, Neuropsychopharmacology.
[23] J. Hoozemans,et al. Physiological and pathophysiological functions of cell cycle proteins in post-mitotic neurons: implications for Alzheimer’s disease , 2015, Acta Neuropathologica.
[24] A. Ittner,et al. p38 MAP kinase-mediated NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of Alzheimer’s disease , 2014, Acta neuropathologica communications.
[25] N. Haass,et al. Real‐time cell cycle imaging during melanoma growth, invasion, and drug response , 2014, Pigment cell & melanoma research.
[26] R. Medema,et al. Transient activation of p53 in G2 phase is sufficient to induce senescence. , 2014, Molecular cell.
[27] R. Young,et al. D-cyclins repress apoptosis in hematopoietic cells by controlling death receptor Fas and its ligand FasL. , 2014, Developmental cell.
[28] K. Ressler,et al. AAV2 production with optimized N/P ratio and PEI-mediated transfection results in low toxicity and high titer for in vitro and in vivo applications. , 2013, Journal of virological methods.
[29] Dominik Fröhlich,et al. Glial Promoter Selectivity following AAV-Delivery to the Immature Brain , 2013, PloS one.
[30] R. Kayed,et al. Molecular mechanisms of amyloid oligomers toxicity. , 2012, Journal of Alzheimer's disease : JAD.
[31] R. Fisher. The CDK Network: Linking Cycles of Cell Division and Gene Expression. , 2012, Genes & cancer.
[32] M. Pallàs,et al. Role of Cell Cycle Re-Entry in Neurons: A Common Apoptotic Mechanism of Neuronal Cell Death , 2012, Neurotoxicity Research.
[33] Á. Almeida. Regulation of APC/C-Cdh1 and Its Function in Neuronal Survival , 2012, Molecular Neurobiology.
[34] T. Arendt. Cell Cycle Activation and Aneuploid Neurons in Alzheimer's Disease , 2012, Molecular Neurobiology.
[35] N. Ayad,et al. The APC/C Ubiquitin Ligase: From Cell Biology to Tumorigenesis , 2011, Front. Oncol..
[36] A. Karabay,et al. Cell cycle markers have different expression and localization patterns in neuron-like PC12 cells and primary hippocampal neurons , 2011, Neuroscience Letters.
[37] Inna Kuperstein,et al. Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio , 2010, The EMBO journal.
[38] Jürgen Götz,et al. Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.
[39] Chang Zhu,et al. Cdh1–APC is involved in the differentiation of neural stem cells into neurons , 2010, Neuroreport.
[40] T. Arendt,et al. Neuronal Aneuploidy in Health and Disease: A Cytomic Approach to Understand the Molecular Individuality of Neurons , 2009, International journal of molecular sciences.
[41] Á. Almeida,et al. Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity , 2008, The EMBO journal.
[42] D. Colomer,et al. Cyclin D1 mediates resistance to apoptosis through upregulation of molecular chaperones and consequent redistribution of cell death regulators , 2008, Oncogene.
[43] R. Newman,et al. Fucci: street lights on the road to mitosis. , 2008, Chemistry and Biology.
[44] F. Guillemot,et al. Licensing regulators Geminin and Cdt1 identify progenitor cells of the mouse CNS in a specific phase of the cell cycle , 2007, Neuroscience.
[45] T. Arendt,et al. Aneuploidy and DNA Replication in the Normal Human Brain and Alzheimer's Disease , 2007, The Journal of Neuroscience.
[46] P. Jackson. Developmental neurobiology: A destructive switch for neurons , 2006, Nature.
[47] S. Moreno,et al. Cdh1/Hct1-APC Is Essential for the Survival of Postmitotic Neurons , 2005, The Journal of Neuroscience.
[48] L. Ittner,et al. The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1. , 2005, Biochemistry.
[49] P. Hinds,et al. Cyclins and cdks in development and cancer: a perspective , 2005, Oncogene.
[50] J. Bartek,et al. Cell division: The heart of the cycle , 2004, Nature.
[51] Guo-Jun Zhang,et al. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex , 2004, Nature.
[52] A. Murray,et al. Recycling the Cell Cycle Cyclins Revisited , 2004, Cell.
[53] Karl Herrup,et al. Neuronal Cell Death Is Preceded by Cell Cycle Events at All Stages of Alzheimer's Disease , 2003, The Journal of Neuroscience.
[54] G. Krafft,et al. In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis* , 2003, The Journal of Biological Chemistry.
[55] Y. A. Minamishima,et al. Modulation of p53 and p73 levels by cyclin G: implication of a negative feedback regulation , 2003, Oncogene.
[56] S. Kügler,et al. Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area , 2003, Gene Therapy.
[57] T. Arendt,et al. Cyclin D1 and Cyclin E Are Co‐Localized with Cyclo‐Oxygenase 2 (COX‐2) in Pyramidal Neurons in Alzheimer Disease Temporal Cortex , 2002, Journal of neuropathology and experimental neurology.
[58] Frederick R. Cross,et al. APC-dependent proteolysis of the mitotic cyclin Clb2 is essential for mitotic exit , 2002, Nature.
[59] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[60] M. Memo,et al. Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path? , 2001, Trends in Neurosciences.
[61] C. Pickart,et al. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[62] M. Smith,et al. Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease. , 1999, Medical hypotheses.
[63] K. Herrup,et al. Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain , 1998, The Journal of Neuroscience.
[64] B. Sommer,et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[65] M. Smith,et al. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. , 1997, The American journal of pathology.
[66] G. Jicha,et al. Aberrant Expression of Mitotic Cdc2/Cyclin B1 Kinase in Degenerating Neurons of Alzheimer’s Disease Brain , 1997, The Journal of Neuroscience.
[67] U. Gärtner,et al. Expression of the cyclin‐dependent kinase inhibitor p16 in Alzheimer's disease , 1996, Neuroreport.
[68] C. Lippa,et al. Ki‐67 Immunoreactivity in Alzheimer's Disease and Other Neurodegenerative Disorders , 1995, Journal of neuropathology and experimental neurology.
[69] C. Stevens,et al. Early Transient Neuronal CyclinD1 Expression Precedes Atrophy in the Frontal Cortex of APP23 Mice , 2019 .
[70] Loredana Spoerri,et al. Real-Time Cell Cycle Imaging in a 3D Cell Culture Model of Melanoma. , 2017, Methods in molecular biology.
[71] Atsushi Miyawaki,et al. [Visualizing spatiotemporal dynamics of multicellular cell-cycle progression]. , 2012, Seikagaku. The Journal of Japanese Biochemical Society.
[72] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[73] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[74] Jürgen Götz,et al. Primary support cultures of hippocampal and substantia nigra neurons , 2008, Nature Protocols.
[75] T. Arendt,et al. Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease. , 1998, Journal of neural transmission. Supplementum.
[76] R M Chau,et al. [Cell cycle and apoptosis]. , 1996, Sheng li ke xue jin zhan [Progress in physiology].
[77] W. B. Stine,et al. Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress. , 1995, Experimental neurology.
[78] D. Dickson,et al. Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments. , 1995, The American journal of pathology.
[79] J. H. Austin,et al. Increased aneuploidy in Alzheimer disease. , 1979, American journal of medical genetics.